Below is Cleveland Clinic’s list of the top ten medical innnovations for their potential impact on patient care in the coming year. (I’ll add my two cents afterward.)
Use of circulating tumor cell technology. Improves adjustments to cancer treatment, particularly for patients with repeat cancer
Warm organ perfusion device. Increases from 4 to 12 [...]
This article in Forbes is interesting for its stranglehold on the obvious.
Noting that the shares of surgical device maker, Cardica, and gene therapy device maker, Cardium Therapeutics, have fallen of late, making them potential acquisition targets which, of course, virtually all med-tech companies are anyway. In fact, and to give Forbes credit, their point [...]